Home » Topics » Regulatory

Regulatory
RSS

New use claimed for olanzapine

Nov. 26, 1996

Approval recommended for Elan's gel formulation of diazepam

Nov. 21, 1996

First regulatory approval for impotence treatment

Nov. 21, 1996

Otsuka discloses inhibitor of TNF-alpha production

Nov. 21, 1996

FDA approves treatment for homocystinuria

Nov. 19, 1996

FDA approves once-daily antihypertensive combination

Nov. 15, 1996

More convenient formulation of Azmacort cleared for asthma prophylaxis

Nov. 15, 1996

New MS treatment approved in Israel

Nov. 15, 1996

New formulation of Leukine approved by FDA

Nov. 15, 1996

New formulation of amifostine covered by U.S. patent

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...